These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 4811478)

  • 1. Cefazolin vs cephalothin and cephaloridine. A comparison of their clinical pharmacology.
    Regamey C; Gordon RC; Kirby WM
    Arch Intern Med; 1974 Mar; 133(3):407-10. PubMed ID: 4811478
    [No Abstract]   [Full Text] [Related]  

  • 2. Cephaloridine versus cephalothin: relation of the kidney to blood level differences after parenteral administration.
    Tuano SB; Brodie JL; Kirby WM
    Antimicrob Agents Chemother (Bethesda); 1966; 6():101-6. PubMed ID: 5985234
    [No Abstract]   [Full Text] [Related]  

  • 3. Comparative serum levels and urinary recovery of cefazolin, cephaloridine, and cephalothin in man.
    Cahn MM; Levy EJ; Actor P; Pauls JF
    J Clin Pharmacol; 1974 Jan; 14(1):61-6. PubMed ID: 4588120
    [No Abstract]   [Full Text] [Related]  

  • 4. [Body fluid concentration of parenterally administered cephalosporin C derivatives].
    Seiga K; Yamaji K; Sugiyama Y
    Jpn J Antibiot; 1972 Aug; 25(4):233-8. PubMed ID: 4539470
    [No Abstract]   [Full Text] [Related]  

  • 5. Pharmacokinetics of parenteral sodium cephalexin in comparison with cephalothin and cefazolin.
    Regamey C; Libke RD; Clarke JT; Kirby WM
    Infection; 1974; 2(3):132-6. PubMed ID: 4415038
    [No Abstract]   [Full Text] [Related]  

  • 6. Cefazolin, a new semisynthetic cephalosporin antibiotic. 3. Absorption, excretion and tissue distribution in parenteral administration.
    Nishida M; Matsubara T; Murakawa T; Mine Y; Yokota Y; Goto S; Kuwahara S
    J Antibiot (Tokyo); 1970 Apr; 23(4):184-94. PubMed ID: 5423363
    [No Abstract]   [Full Text] [Related]  

  • 7. Characteristics of biliary excretion of cefazolin and other cephalosporins with reference to the relationship between serum levels and administration conditions.
    Nishida M; Murakawa T; Matsubara T; Kohno Y; Yokota Y
    Chemotherapy; 1976; 22(1):30-6. PubMed ID: 1253628
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Cephazolin: pharmacology compared with that of 2 other cephalosporins].
    Guibert J; Lavarde M; Goldstein F
    Nouv Presse Med; 1974 Apr; 3(0):19-20. PubMed ID: 4837110
    [No Abstract]   [Full Text] [Related]  

  • 9. Binding of cephalothin, cephaloridine and cefazolin to human serum proteins.
    Miyake Y; Ebata M
    J Antibiot (Tokyo); 1976 Jun; 29(6):667. PubMed ID: 950323
    [No Abstract]   [Full Text] [Related]  

  • 10. Studies on chemotherapy during the perinatal period with special reference to such derivatives of cephalosporin C as cefazolin, cephaloridine and cephalothin.
    Fukada M
    Jpn J Antibiot; 1973 Jun; 26(3):197-214. PubMed ID: 4542543
    [No Abstract]   [Full Text] [Related]  

  • 11. [Cefazolin, a new broad-spectrum antibiotic (author's transl)].
    Simon C; Malerczyk V; Brahmstaedt E; Toeller W
    Dtsch Med Wochenschr; 1973 Dec; 98(51):2448-50. PubMed ID: 4767675
    [No Abstract]   [Full Text] [Related]  

  • 12. Distribution of some newer antibiotics within the kidney interstitium: a therapeutic consideration in pyelonephritis.
    Cockett AT; Moore RS; Roberts AP
    Invest Urol; 1967 Nov; 5(3):250-9. PubMed ID: 6073633
    [No Abstract]   [Full Text] [Related]  

  • 13. Pharmacokinetics of cefazolin compared with four other cephalosporins.
    Kirby WM; Regamey C
    J Infect Dis; 1973 Oct; 128():Suppl:S341-6. PubMed ID: 4744015
    [No Abstract]   [Full Text] [Related]  

  • 14. Studies on the pharmacokinetics of cefoxitin, cefuroxime, cephaloridine and cephalothin using subcutaneous tissue cages.
    Rylander M; Holm SE; Norrby R; Brorson JE
    Scand J Infect Dis Suppl; 1978; (13):52-7. PubMed ID: 278147
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biliary tract excretion of cefazolin, cephalothin, and cephaloridine in the presence of biliary tract disease.
    Ratzan KR; Ruiz C; Irvin GL
    Antimicrob Agents Chemother; 1974 Oct; 6(4):426-31. PubMed ID: 4157339
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Cephalosporins from the clinical viewpoint].
    Regamey C
    Int J Clin Pharmacol Biopharm; 1975 Mar; 11(2):93-102. PubMed ID: 1095504
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inactivation of cefazolin, cephaloridine, and cephalothin by methicillin-sensitive and methicillin-resistant strains of Staphylococcus aureus.
    Regamey C; Libke RD; Engelking ER; Clarke JT; Kirby MM
    J Infect Dis; 1975 Mar; 131(3):291-4. PubMed ID: 1039311
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of absorption and excretion of cefazolin with cephalothin and cephapirin.
    Shimizu T
    Jpn J Antibiot; 1975 Aug; 28(4):542-8. PubMed ID: 1160145
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distribution of parenteral ampicillin and cephalosporins in late pregnancy.
    Stewart KS; Shafi M; Andrews J; Williams JD
    J Obstet Gynaecol Br Commonw; 1973 Oct; 80(10):902-8. PubMed ID: 4757497
    [No Abstract]   [Full Text] [Related]  

  • 20. [Pharmacodynamics of cephaloridine and cephalothin combined with sulfalene in rabbits].
    Bobrov VI; Beletskaia GT; Iakovlev VP
    Antibiotiki; 1984 Nov; 29(11):823-5. PubMed ID: 6524880
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.